Replies to post #329902 on Avid Bioservices Inc (CDMO)

[EndoTarget]

OK 1.7B for 6.8X250MM so 50MM is roughly 340MM or 5.67$ with 60MM share B4 growth,

Avid is strongly undervalued now. Target price is 12$ within 3 years.

[peregr]

Very good chart. Lots of opportunities for consolidation in a fragmented industry.
Also appears that both Gallus and Brammer from start to sale were 3-4 year deals (with all the employees kept).Avid has a pretty good head start on that cycle.Probably why there is so much institutional interest.
Just don't understand what is taking Lias so long on the revenue generation with the available capacity. He really needs to step it up on guidance by the next call, or get some new development people.